BELLUS Health Inc Share Price Toronto S.E.
Equities
CA07987C1059
Biotechnology & Medical Research
Sales 2021 | 16K 11.73K 933K | Sales 2022 | 16K 11.73K 933K | Capitalization | 1.03B 758M 60.29B |
---|---|---|---|---|---|
Net income 2021 | -71M -52.06M -4.14B | Net income 2022 | -76M -55.72M -4.43B | EV / Sales 2021 | 36,461 x |
Net cash position 2021 | 248M 182M 14.45B | Net cash position 2022 | 336M 246M 19.57B | EV / Sales 2022 | 43,652 x |
P/E ratio 2021 |
-8.96
x | P/E ratio 2022 |
-12.4
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 81.52% |
Managers | Title | Age | Since |
---|---|---|---|
Roberto Bellini
CEO | Chief Executive Officer | 44 | 04/06/09 |
Jeremy Martin
PSD | President | - | - |
Chairman | 77 | 31/12/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 77 | 31/12/01 | |
Franklin Berger
BRD | Director/Board Member | 74 | 30/04/10 |
Director/Board Member | 52 | 31/05/09 |
1st Jan change | Capi. | |
---|---|---|
+5.66% | 111B | |
+11.23% | 105B | |
-12.15% | 22.34B | |
-3.49% | 21.93B | |
-6.17% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |